Campadelli-Fiume G - Search Results

1

Retargeting Strategies for Oncolytic Herpes Simplex Viruses.

Campadelli-Fiume G, Petrovic B, Leoni V, Gianni T, Avitabile E, Casiraghi C, Gatta V. Campadelli-Fiume G, et al. Viruses. 2016 Feb 26;8(3):63. doi: 10.3390/v8030063. Viruses. 2016. PMID: 26927159 Free PMC article. Review.

2

The multipartite system that mediates entry of herpes simplex virus into the cell.

Campadelli-Fiume G, Amasio M, Avitabile E, Cerretani A, Forghieri C, Gianni T, Menotti L. Campadelli-Fiume G, et al. Rev Med Virol. 2007 Sep-Oct;17(5):313-26. doi: 10.1002/rmv.546. Rev Med Virol. 2007. PMID: 17573668 Review.

3

Rethinking herpes simplex virus: the way to oncolytic agents.

Campadelli-Fiume G, De Giovanni C, Gatta V, Nanni P, Lollini PL, Menotti L. Campadelli-Fiume G, et al. Rev Med Virol. 2011 Jul;21(4):213-26. doi: 10.1002/rmv.691. Epub 2011 May 27. Rev Med Virol. 2011. PMID: 21626603 Review.

4

Viral and cellular contributions to herpes simplex virus entry into the cell.

Campadelli-Fiume G, Menotti L, Avitabile E, Gianni T. Campadelli-Fiume G, et al. Curr Opin Virol. 2012 Feb;2(1):28-36. doi: 10.1016/j.coviro.2011.12.001. Epub 2012 Jan 4. Curr Opin Virol. 2012. PMID: 22440963 Review.

5

The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors.

Gatta V, Petrovic B, Campadelli-Fiume G. Gatta V, et al. PLoS Pathog. 2015 May 21;11(5):e1004907. doi: 10.1371/journal.ppat.1004907. eCollection 2015 May. PLoS Pathog. 2015. PMID: 25996983 Free PMC article.

6

A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.

Leoni V, Gatta V, Casiraghi C, Nicosia A, Petrovic B, Campadelli-Fiume G. Leoni V, et al. J Virol. 2017 Apr 28;91(10):e00067-17. doi: 10.1128/JVI.00067-17. Print 2017 May 15. J Virol. 2017. PMID: 28250120 Free PMC article.

7

Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins.

Petrovic B, Gianni T, Gatta V, Campadelli-Fiume G. Petrovic B, et al. PLoS Pathog. 2017 Apr 19;13(4):e1006352. doi: 10.1371/journal.ppat.1006352. eCollection 2017 Apr. PLoS Pathog. 2017. PMID: 28423057 Free PMC article.

8

Simultaneous Insertion of Two Ligands in gD for Cultivation of Oncolytic Herpes Simplex Viruses in Noncancer Cells and Retargeting to Cancer Receptors.

Leoni V, Petrovic B, Gianni T, Gatta V, Campadelli-Fiume G. Leoni V, et al. J Virol. 2018 Feb 26;92(6):e02132-17. doi: 10.1128/JVI.02132-17. Print 2018 Mar 15. J Virol. 2018. PMID: 29263255 Free PMC article.

9

Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells.

Petrovic B, Leoni V, Gatta V, Zaghini A, Vannini A, Campadelli-Fiume G. Petrovic B, et al. J Virol. 2018 Feb 26;92(6):e02122-17. doi: 10.1128/JVI.02122-17. Print 2018 Mar 15. J Virol. 2018. PMID: 29263257 Free PMC article.

10

HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses.

Menotti L, Avitabile E, Gatta V, Malatesta P, Petrovic B, Campadelli-Fiume G. Menotti L, et al. Viruses. 2018 Jun 30;10(7):352. doi: 10.3390/v10070352. Viruses. 2018. PMID: 29966356 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters